Lymphatic injury and regeneration in cardiac allografts

Transplantation

Volumn 89, Issue 5, 2010, Pages 500-508

  Rinda Soong, Thing ^a   Pathak, Arvind P ^a   Asano, Hiroshi ^a,b   Fox Talbot, Karen ^a   Baldwin, William M ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Allograft; Alloimmunity; Heart; Lymphatics; Rejection

Indexed keywords

BIOLOGICAL MARKER; CD8 ANTIGEN; CHLORDANE; HYALURONIC ACID;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL INFILTRATION; CELL STRUCTURE; CONTROLLED STUDY; EPICARDIUM; GRAFT RECIPIENT; HEART BLOOD VESSEL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOLOGY; ISOGRAFT; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; MACROPHAGE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; RETRANSPLANTATION; T LYMPHOCYTE; TISSUE REGENERATION;

ANASTOMOSIS, SURGICAL; ANIMALS; AORTA; HEART TRANSPLANTATION; ISOANTIGENS; LEUKOCYTES, MONONUCLEAR; LYMPHATIC SYSTEM; MALE; PULMONARY ARTERY; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; RECEPTORS, CELL SURFACE; REGENERATION; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 77949376756     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c73c34     Document Type: Article

References (44)

1. Kong XQ, Wang LX, Kong DG. Cardiac lymphatic interruption is a major cause for allograft failure after cardiac transplantation. Lymphat Res Biol 2007; 5: 45.
2. Ji RC. Characteristics of lymphatic endothelial cells in physiological and pathological conditions. Histol Histopathol 2005; 20: 155.
3. Symbas PN, Cooper T, Gantner GE Jr, et al. Lymphatics of the heart: Anatomic effects following interruption of the drainage of the cardiac lymph. Arch Path 1966; 81: 573.
4. Symbas PN, Schlant RC, Gravanis MB, et al. Pathologic and functional effects on the heart following interruption of the cardiac lymph drainage. J Thorac Cardiovasc Surg 1969; 57: 577.
5. Jellinek H, Gabor G, Solti F, et al. The problem of the coronary changes due to disturbance of vascular wall permeability. Angiology 1967; 18: 179.
6. Kline IK, Miller AJ, Pick R, et al. The relationship between human endocardial fibroelastosis and obstruction of the cardiac lymphatics. Circulation 1964; 30: 728.
7. Ji RC. Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol 2006; 4: 83.
8. Stacker SA, Hughes RA, Willams RA, et al. Current strategies for modulating lymphangiogenesis signaling pathways in human disease. Curr Med Chem 2006; 13: 783.
9. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the meta-static spread of tumor cells via the lymphatics. Nat Med 2001; 7: 186.
10. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 1751.
11. Ishikawa Y, Akishima-Fukasawa Y, Ito K, et al. Lymphangiogenesis in myocardial remodeling after infarction. Histopathology 2007; 51: 345.
12. Liersch R, Detmar M. Lymphangiogenesis in development and disease. Thromb Haemost 2007; 98: 304.
13. Veikkola T, Lohela M, Ikenberg K, et al. Intrinsic versus microenviron-mental regulation of lymphatic endothelial cell phenotype and function. FASEB J 2003; 17: 2006.
14. Stacker SA, Hughes RA, Achen MG. Molecular targeting of lymphatics for therapy. Curr Pharm Des 2004; 10: 65.
15. Szuba A, Skobe M, Karkkainen MJ, et al. Therapeutic lymphangiogen-esis with human recombinant VEGF-C. FASEB J 2002; 16: 1985.
16. Kim H, Dumont DJ. Molecular mechanisms in lymphangiogenesis: Model systems and implications in human disease. Clin Genet 2003; 64: 282.
17. Cursiefen C, Chen L, Dana MR, et al. Corneal lymphangiogenesis: Evidence, mechanisms, and implications for corneal transplant immunology. Cornea 2003; 22: 273.
18. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangio-genesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004; 113: 1040.
19. KerjaschkiD,Regele HM, MoosbergerI,etal. Lymphatic neoangiogen-esis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603.
20. Thaunat O, Patney N, Morelon E, et al. Lymphoid neogenesis in chronic rejection: The murderer is in the house. Curr Opin Immunol 2006; 18: 576.
21. Stuht S, Gwinner W, Franz I, et al. Lymphatic neoangiogenesis in human renal allografts: Results from sequential protocol biopsies. Am J Transplant 2007; 7: 377.
22. Di Carlo E, D'Antuono T, Continto S, et al. Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections. Am J Transplant 2007; 7: 201.
23. Jonigk D, Lehmann U, Stuht S, et al. Recipient-derived neoangiogen-esis of arterioles and lymphatics in quilty lesions of cardiac allografts. Transplantation 2007; 84: 1335.
24. StewartS,Winters GL, Fishbein MC,et al. Revisionofthe 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710.
25. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144: 789.
26. Jackson DG. The lymphatics revisited: New perspectives from the hya-luronan receptor LYVE-1. Trends Cardiovasc Med 2003; 13: 1.
27. Jackson DG. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 2004; 112: 526.
28. Ono K, Kindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
29. Pathak AP, Artemov D, Neeman M, et al. Lymph node metastasis in breast cancer xenografts is associated with increased regions of ex-travascular drain, lymphatic vessel area, and invasive phenotype. Cancer Res 2006; 66: 5151.
30. Sacchi G, Weber E, Aglianò M, et al. Lymphatic vessels of the human heart: Precollectors and collecting vessels. A morpho-structural study. J Submicrosc Cytol Pathol 1999; 31: 515.
31. Davis MJ, Davis AM, Ku CW, et al. Myogenic constriction and dilation of isolated lymphatic vessels. Am J Physiol Heart Circ Physiol 2009; 296: H293.
32. Ji RC. Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players. Curr Med Chem 2007; 14: 2359.
33. Laine GA, Granger HJ. Microvascular, interstitial, and lymphatic interactions in the normal heart. Am J Physiol 1985; 249: H834.
34. Malek P, Vrubel J. Lymphatic system and organ transplantation. Lym-phology 1968; 1: 4.
35. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol Lond 1896; 19: 312.
36. Geissler HJ, Dashkevich A, Fischer UM, et al. First year changes of myocardial lymphatic endothelial markers in heart transplant recipients. Eur J Cardiothorac Surg 2006; 29: 767.
37. Demetris AJ, Murase N, Ye Q, et al. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 1997; 150: 563.
38. Salmi M, Koskinen K, Henttinen T, et al. CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood 2004; 104: 3849.
39. Nibbs RJ, Kriehuber E, Ponath PD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001; 158:867.
40. Ilano AL, McConnell MV, Gurley KE, et al. Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low-and high-responder rat strains. J Immunol 1989; 143: 2828.
41. Delfs MW, Furukawa Y, Mitchell RN, et al. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Transplantation 2001; 71: 606.
42. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest 2005; 115:2316.
43. Kerjaschki D, Huttery N, Raab I, et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 2006; 12: 230.
44. Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005; 115: 2363.